• レポートコード:GIR-22E7614 • 出版社/出版日:GlobalInfoResearch / 2022年5月 • レポート形態:英文、PDF、103ページ • 納品方法:Eメール(2~3営業日) • 産業分類:医療機器 |
Single User | ¥522,000 (USD3,480) | ▷ お問い合わせ |
Multi User | ¥783,000 (USD5,220) | ▷ お問い合わせ |
Corporate User | ¥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
人工ペースメーカー市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界の人工ペースメーカーの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。 人工ペースメーカー市場は種類と用途によって区分されます。2017年~2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・暫定的心臓ペーシング、シングルチャンバー心臓ペーシング、ダブルチャンバー心臓ペーシング、その他 用途別セグメントは次のように区分されます。 ・徐脈、心房細動、心不全、失神 世界の人工ペースメーカー市場の主要な市場プレーヤーは以下のとおりです。 ・Medtronic、Abbott、Boston Scientific、BIOTRONIK、Sorin Group、IMZ、Medico、CCC、Pacetronix、Cardioelectronica、Qinming Medical、Neuroiz 地域別セグメントは次の地域・国をカバーします。 ・北米(米国、カナダ、メキシコ) ・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア) ・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア) ・南アメリカ(ブラジル、アルゼンチン、コロンビア) ・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ) 本調査レポートの内容は計15章あります。 ・第1章では、人工ペースメーカー製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な人工ペースメーカーメーカーの企業概要、2019年~2022年までの人工ペースメーカーの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な人工ペースメーカーメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年~2028年までの地域別人工ペースメーカーの販売量、売上、成長性を示しています。 ・第5、6章では、2017年~2028年までの人工ペースメーカーの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2028年までの主要地域での人工ペースメーカー市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および人工ペースメーカーの産業チェーンを掲載しています。 ・第13、14、15章では、人工ペースメーカーの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報(企業概要、製品概要、販売量、価格、売上):Medtronic、Abbott、Boston Scientific、BIOTRONIK、Sorin Group、IMZ、Medico、CCC、Pacetronix、Cardioelectronica、Qinming Medical、Neuroiz ・メーカー別市場シェア ・地域別市場分析2017年-2028年 ・種類別分析2017年-2028年:暫定的心臓ペーシング、シングルチャンバー心臓ペーシング、ダブルチャンバー心臓ペーシング、その他 ・用途別分析2017年-2028年:徐脈、心房細動、心不全、失神 ・人工ペースメーカーの北米市場規模2017年-2028年:アメリカ、カナダ、メキシコ ・人工ペースメーカーのヨーロッパ市場規模2017年-2028年:ドイツ、イギリス、フランス、ロシア、イタリア ・人工ペースメーカーのアジア市場規模2017年-2028年:中国、日本、韓国、インド、東南アジア、オーストラリア ・人工ペースメーカーの南米市場規模2017年-2028年:ブラジル、アルゼンチン ・人工ペースメーカーの中東・アフリカ市場規模2017年-2028年:サウジアラビア、トルコ、エジプト、南アフリカ ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Artificial Pacemaker market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Artificial Pacemaker market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Bradycardia accounting for % of the Artificial Pacemaker global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Temporary Cardiac Pacing segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Artificial Pacemaker include Medtronic, Abbott, Boston Scientific, BIOTRONIK, and Sorin Group, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Artificial Pacemaker market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Temporary Cardiac Pacing
Single Chamber Cardiac Pacing
Double-Chamber Cardiac Pacing
Others
Market segment by Application can be divided into
Bradycardia
Atrial Fibrillation
Heart Failure
Syncope
The key market players for global Artificial Pacemaker market are listed below:
Medtronic
Abbott
Boston Scientific
BIOTRONIK
Sorin Group
IMZ
Medico
CCC
Pacetronix
Cardioelectronica
Qinming Medical
Neuroiz
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Artificial Pacemaker product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Artificial Pacemaker, with price, sales, revenue and global market share of Artificial Pacemaker from 2019 to 2022.
Chapter 3, the Artificial Pacemaker competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Artificial Pacemaker breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Artificial Pacemaker market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Pacemaker.
Chapter 13, 14, and 15, to describe Artificial Pacemaker sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Artificial Pacemaker Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Artificial Pacemaker Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Temporary Cardiac Pacing
1.2.3 Single Chamber Cardiac Pacing
1.2.4 Double-Chamber Cardiac Pacing
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Artificial Pacemaker Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Bradycardia
1.3.3 Atrial Fibrillation
1.3.4 Heart Failure
1.3.5 Syncope
1.4 Global Artificial Pacemaker Market Size & Forecast
1.4.1 Global Artificial Pacemaker Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Artificial Pacemaker Sales in Volume (2017-2028)
1.4.3 Global Artificial Pacemaker Price (2017-2028)
1.5 Global Artificial Pacemaker Production Capacity Analysis
1.5.1 Global Artificial Pacemaker Total Production Capacity (2017-2028)
1.5.2 Global Artificial Pacemaker Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Artificial Pacemaker Market Drivers
1.6.2 Artificial Pacemaker Market Restraints
1.6.3 Artificial Pacemaker Trends Analysis
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Medtronic Details
2.1.2 Medtronic Major Business
2.1.3 Medtronic Artificial Pacemaker Product and Services
2.1.4 Medtronic Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Artificial Pacemaker Product and Services
2.2.4 Abbott Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Boston Scientific
2.3.1 Boston Scientific Details
2.3.2 Boston Scientific Major Business
2.3.3 Boston Scientific Artificial Pacemaker Product and Services
2.3.4 Boston Scientific Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 BIOTRONIK
2.4.1 BIOTRONIK Details
2.4.2 BIOTRONIK Major Business
2.4.3 BIOTRONIK Artificial Pacemaker Product and Services
2.4.4 BIOTRONIK Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Sorin Group
2.5.1 Sorin Group Details
2.5.2 Sorin Group Major Business
2.5.3 Sorin Group Artificial Pacemaker Product and Services
2.5.4 Sorin Group Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 IMZ
2.6.1 IMZ Details
2.6.2 IMZ Major Business
2.6.3 IMZ Artificial Pacemaker Product and Services
2.6.4 IMZ Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Medico
2.7.1 Medico Details
2.7.2 Medico Major Business
2.7.3 Medico Artificial Pacemaker Product and Services
2.7.4 Medico Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 CCC
2.8.1 CCC Details
2.8.2 CCC Major Business
2.8.3 CCC Artificial Pacemaker Product and Services
2.8.4 CCC Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Pacetronix
2.9.1 Pacetronix Details
2.9.2 Pacetronix Major Business
2.9.3 Pacetronix Artificial Pacemaker Product and Services
2.9.4 Pacetronix Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Cardioelectronica
2.10.1 Cardioelectronica Details
2.10.2 Cardioelectronica Major Business
2.10.3 Cardioelectronica Artificial Pacemaker Product and Services
2.10.4 Cardioelectronica Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Qinming Medical
2.11.1 Qinming Medical Details
2.11.2 Qinming Medical Major Business
2.11.3 Qinming Medical Artificial Pacemaker Product and Services
2.11.4 Qinming Medical Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Neuroiz
2.12.1 Neuroiz Details
2.12.2 Neuroiz Major Business
2.12.3 Neuroiz Artificial Pacemaker Product and Services
2.12.4 Neuroiz Artificial Pacemaker Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Artificial Pacemaker Breakdown Data by Manufacturer
3.1 Global Artificial Pacemaker Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Artificial Pacemaker Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Artificial Pacemaker
3.4 Market Concentration Rate
3.4.1 Top 3 Artificial Pacemaker Manufacturer Market Share in 2021
3.4.2 Top 6 Artificial Pacemaker Manufacturer Market Share in 2021
3.5 Global Artificial Pacemaker Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Artificial Pacemaker Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Artificial Pacemaker Market Size by Region
4.1.1 Global Artificial Pacemaker Sales in Volume by Region (2017-2028)
4.1.2 Global Artificial Pacemaker Revenue by Region (2017-2028)
4.2 North America Artificial Pacemaker Revenue (2017-2028)
4.3 Europe Artificial Pacemaker Revenue (2017-2028)
4.4 Asia-Pacific Artificial Pacemaker Revenue (2017-2028)
4.5 South America Artificial Pacemaker Revenue (2017-2028)
4.6 Middle East and Africa Artificial Pacemaker Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Artificial Pacemaker Sales in Volume by Type (2017-2028)
5.2 Global Artificial Pacemaker Revenue by Type (2017-2028)
5.3 Global Artificial Pacemaker Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Artificial Pacemaker Sales in Volume by Application (2017-2028)
6.2 Global Artificial Pacemaker Revenue by Application (2017-2028)
6.3 Global Artificial Pacemaker Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Artificial Pacemaker Sales by Type (2017-2028)
7.2 North America Artificial Pacemaker Sales by Application (2017-2028)
7.3 North America Artificial Pacemaker Market Size by Country
7.3.1 North America Artificial Pacemaker Sales in Volume by Country (2017-2028)
7.3.2 North America Artificial Pacemaker Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Artificial Pacemaker Sales by Type (2017-2028)
8.2 Europe Artificial Pacemaker Sales by Application (2017-2028)
8.3 Europe Artificial Pacemaker Market Size by Country
8.3.1 Europe Artificial Pacemaker Sales in Volume by Country (2017-2028)
8.3.2 Europe Artificial Pacemaker Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Artificial Pacemaker Sales by Type (2017-2028)
9.2 Asia-Pacific Artificial Pacemaker Sales by Application (2017-2028)
9.3 Asia-Pacific Artificial Pacemaker Market Size by Region
9.3.1 Asia-Pacific Artificial Pacemaker Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Artificial Pacemaker Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Artificial Pacemaker Sales by Type (2017-2028)
10.2 South America Artificial Pacemaker Sales by Application (2017-2028)
10.3 South America Artificial Pacemaker Market Size by Country
10.3.1 South America Artificial Pacemaker Sales in Volume by Country (2017-2028)
10.3.2 South America Artificial Pacemaker Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Artificial Pacemaker Sales by Type (2017-2028)
11.2 Middle East & Africa Artificial Pacemaker Sales by Application (2017-2028)
11.3 Middle East & Africa Artificial Pacemaker Market Size by Country
11.3.1 Middle East & Africa Artificial Pacemaker Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Artificial Pacemaker Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Artificial Pacemaker and Key Manufacturers
12.2 Manufacturing Costs Percentage of Artificial Pacemaker
12.3 Artificial Pacemaker Production Process
12.4 Artificial Pacemaker Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Artificial Pacemaker Typical Distributors
13.3 Artificial Pacemaker Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer